Boston Scientific launches Vercise primary cell and Vercise Gevia deep brain stimulation systems with directional leads

The new systems, which were recently approved by the U.S. Food and Drug Administration (FDA), feature technology designed to allow physicians to control the range, shape, position and

More From BioPortfolio on "Boston Scientific launches Vercise primary cell and Vercise Gevia deep brain stimulation systems with directional leads"